(1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol

C21H29NO4 — CID 50924237

IUPAC(1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol
SMILESC=CCN1CC[C@@]23CC(O)C(OC)C[C@@H]2[C@@H]1Cc1ccc(OC)c(O)c13
InChIInChI=1S/C21H29NO4/c1-4-8-22-9-7-21-12-16(23)18(26-3)11-14(21)15(22)10-13-5-6-17(25-2)20(24)19(13)21/h4-6,14-16,18,23-24H,1,7-12H2,2-3H3/t14-,15+,16?,18?,21-/m1/s1
InChIKeyKFNCXPSFZMODBC-IVUBAFOSSA-N
MW359.47 g/mol
LogP2.24
Rot. Bonds4

About (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol

(1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol (PubChem CID 50924237) has the molecular formula C21H29NO4 and a molecular weight of 359.47 g/mol. Its IUPAC name is (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol.

Molecular Properties

Compound Name(1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol
PubChem CID50924237
Molecular FormulaC21H29NO4
Molecular Weight359.47 g/mol
Exact Mass359.21
IUPAC Name(1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol
SMILESC=CCN1CC[C@@]23CC(O)C(OC)C[C@@H]2[C@@H]1Cc1ccc(OC)c(O)c13
InChIInChI=1S/C21H29NO4/c1-4-8-22-9-7-21-12-16(23)18(26-3)11-14(21)15(22)10-13-5-6-17(25-2)20(24)19(13)21/h4-6,14-16,18,23-24H,1,7-12H2,2-3H3/t14-,15+,16?,18?,21-/m1/s1
InChIKeyKFNCXPSFZMODBC-IVUBAFOSSA-N
XLogP2.24
TPSA62.16 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500359.47
LogP ≤ 52.24
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol?
The IUPAC name of (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol (CID 50924237) is (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol.
What is the SMILES notation for (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol?
The canonical SMILES for (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol is C=CCN1CC[C@@]23CC(O)C(OC)C[C@@H]2[C@@H]1Cc1ccc(OC)c(O)c13.
What is the InChIKey of (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol?
The InChIKey is KFNCXPSFZMODBC-IVUBAFOSSA-N. The full InChI is InChI=1S/C21H29NO4/c1-4-8-22-9-7-21-12-16(23)18(26-3)11-14(21)15(22)10-13-5-6-17(25-2)20(24)19(13)21/h4-6,14-16,18,23-24H,1,7-12H2,2-3H3/t14-,15+,16?,18?,21-/m1/s1.
What are the key properties of (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol?
(1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol has a molecular weight of 359.47 g/mol, XLogP of 2.24, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,9S,10S)-4,12-dimethoxy-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol is sourced from PubChem (CID 50924237), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).